Proteomic analysis of protein expression and oxidative modification in R6/2 transgenic mice

被引:145
|
作者
Perluigi, M
Poon, HF
Maragos, W
Pierce, WM
Klein, JB
Calabrese, V
Cini, C
De Marco, C
Butterfield, DA [1 ]
机构
[1] Univ Kentucky, Ctr Membrane Sci, Dept Chem, Lexington, KY 40506 USA
[2] Univ Roma La Sapienza, Dept Biochem Sci, I-00185 Rome, Italy
[3] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA
[4] Univ Kentucky, Dept Anat & Neurobiol, Lexington, KY 40536 USA
[5] Univ Louisville, Sch Med, Kidney Dis Program, Louisville, KY 40292 USA
[6] Univ Louisville, Sch Med, Core Proteom Lab, Louisville, KY 40292 USA
[7] Univ Louisville, Sch Med, Dept Pharmacol, Louisville, KY 40292 USA
[8] Vet Affairs Med Ctr, Louisville, KY 40292 USA
[9] Univ Catania, Dept Chem, Biochem Sect, I-95100 Catania, Italy
[10] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40506 USA
关键词
D O I
10.1074/mcp.M500090-MCP200
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Huntington disease (HD) is a hereditary neurodegenerative disorder characterized by motor, psychiatric, and cognitive symptoms. The genetic defect responsible for the onset of the disease, expansion of CAG repeats in exon 1 of the gene that codes for huntingtin on chromosome 4, has been unambiguously identified. On the other hand, the mechanisms by which the mutation causes the disease are not completely understood yet. However, defects in energy metabolism of affected cells may cause oxidative damage, which has been proposed as one of the underlying molecular mechanisms that participate in the etiology of the disease. In our effort to investigate the extent of oxidative damage occurring at the protein level, we used a parallel proteomic approach to identify proteins potentially involved in processes upstream or downstream of the disease-causing huntingtin in a well established HD mouse model (R6/2 transgenic mice). We have demonstrated that the expression levels of dihydrolipoamide S-succinyltransferase and aspartate aminotransferase increase consistently over the course of disease (10-week-old mice). In contrast, pyruvate dehydrogenase expression levels were found to be decreased in 10-week-old HD transgenic mice compared with young (4-week-old) mice. Our experimental approach also led to the identification of oxidatively modified proteins. Six proteins were found to be significantly oxidized in old R6/2 transgenic mice compared with either young transgenic mice or non-transgenic mice. These proteins are alpha-enolase, gamma-enolase (neuron-specific enolase), aconitase, the voltage-dependent anion channel 1, heat shock protein 90, and creatine kinase. Because oxidative damage has proved to play an important role in the pathogenesis and the progression of Huntington disease, our results for the first time identify specific oxidatively modified proteins that potentially contribute to the pathogenesis of Huntington disease.
引用
收藏
页码:1849 / 1861
页数:13
相关论文
共 50 条
  • [1] Reduced activity and protein expression of NOS in R6/2 HD transgenic mice: effects of L-NAME on symptom progression
    Deckel, AW
    Gordinier, A
    Nuttal, D
    Tang, V
    Kuwada, C
    Freitas, R
    Gary, KA
    BRAIN RESEARCH, 2001, 919 (01) : 70 - 81
  • [2] Reduced hippocampal neurogenesis in R6/2 transgenic Huntington's disease mice
    Gil, JMAC
    Mohapel, P
    Araújo, IM
    Popovic, N
    Li, JY
    Brundin, P
    Petersén, Å
    NEUROBIOLOGY OF DISEASE, 2005, 20 (03) : 744 - 751
  • [3] Expression of the Huntington's disease transgene in neural stem cell cultures from R6/2 transgenic mice
    Chu-LaGraff, Q
    Kang, XW
    Messer, A
    BRAIN RESEARCH BULLETIN, 2001, 56 (3-4) : 307 - 312
  • [4] Changes in GAD67 mRNA expression evidenced by in situ hybridization in the brain of R6/2 transgenic mice
    Gourfinkel-An, I
    Parain, K
    Hartmann, A
    Mangiarini, L
    Brice, A
    Bates, G
    Hirsch, EC
    JOURNAL OF NEUROCHEMISTRY, 2003, 86 (06) : 1369 - 1378
  • [5] DNA microarray analysis of striatal gene expression in symptomatic transgenic Huntington's mice (R6/2) reveals neuroinflammation and insulin associations
    Crocker, Susan F.
    Costain, Willard J.
    Robertson, Harold A.
    BRAIN RESEARCH, 2006, 1088 : 176 - 186
  • [6] Chronology of Behavioral Symptoms and Neuropathologic Sequellae in R6/2 Huntington Disease Transgenic Mice
    Newsome, J. T.
    Ferrante, R. J.
    Fellows-Mayle, W.
    Friedlander, R. M.
    JOURNAL OF THE AMERICAN ASSOCIATION FOR LABORATORY ANIMAL SCIENCE, 2011, 50 (05): : 740 - 740
  • [7] SIRT1 EXPRESSION, REGULATION AND ACTIVITY IN R6/2 MICE
    Norremolle, Anne
    Reynolds, Regina
    Petersen, Maria
    Willert, Cecilie
    Heinrich, Marie
    Nymann, Nynne
    Dall, Morten
    Treebak, Jonas T.
    Bjorkqvist, Maria
    Hasholt, Lis
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2016, 87 : A20 - A20
  • [8] Euploidy in somatic cells from R6/2 transgenic Huntington's disease mice
    Åsa Petersén
    Ylva Stewénius
    Maria Björkqvist
    David Gisselsson
    BMC Cell Biology, 6
  • [9] Characterization of somatostatin receptors and associated signaling pathways in pancreas of R6/2 transgenic mice
    Somvanshi, Rishi K.
    Jhajj, Amrit
    Heer, Michael
    Kumar, Ujendra
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2018, 1864 (02): : 359 - 373
  • [10] Longitudinal Biochemical Assay Analysis of Mutant Huntingtin Exon 1 Protein in R6/2 Mice
    Morozko, Eva L.
    Ochaba, Joseph
    Hernandez, Sarah J.
    Lau, Alice
    Sanchez, Isabella
    Orellana, Iliana
    Kopan, Lexi
    Crapser, Joshua
    Duong, Janet H.
    Overman, Julia
    Yeung, Silvia
    Steffan, Joan S.
    Reidling, Jack
    Thompson, Leslie M.
    JOURNAL OF HUNTINGTONS DISEASE, 2018, 7 (04) : 321 - 335